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REVIEW
Haploidentical Stem Cell Transplantation
Nassar of the King Abdullah Medical City, Mecca, Saudi 
Arabia reviewed current attempts to achieve stem cell transplan-
tation across the major histocompatibility barrier using tech-
niques such as conditioning regimen intensity, graft engineering, 
post-transplant cellular therapy and immunosuppression. He 
also discusses initiatives and strategies to overcome the limita-
tions associated with transplant across the MHC barrier.
ORIgInaL RESEaRCh REpORtS
Lymphoproliferative disorders in pediatric liver 
allograft recipients: a review of 212 cases
Khedmat and Taheri of Baqiyatallah Research Center for 
Gastroenterology and Liver Disease, Baqiyatallah University of 
Medical Sciences, Tehran, Iran, found that pediatric PTLD cases 
(<12 years old) were more likely of the polymorphic type and 
polyclonal compared to older children and adults. Other factors 
were not different except for survival analysis at least 4 months 
postdiagnosis. Pediatric liver recipients developing PTLD have 
relatively better disease presentation and behavior than that in 
adults, but stomach involvement was more frequent.
Intersite validations of the pixel-wise method for 
liver R2* analysis in transfusion-dependent thalas-
semia patients: a more accessible and affordable di-
agnostic technology
Saiviroonporn and colleagues  studying patients at Siriraj 
Hospital, Mahidol University, Bangkok, Thailand,  evaluated 
an approach that can reliably provide an accurate alternative for 
liver iron determination  and is a more affordable technology for 
under-funded thalassaemia patients in a setting where resources 
are limited.
Bcl-2 protein expression in mucoepidermoid carci-
noma of salivary glands: a single institution experi-
ence
In a retrospective review of 40 cases, Janjua and colleagues from 
the Rawal Institute of Health Sciences, Islamabad, and Armed 
Forces Institute of Pathology, Rawalpindi, Pakistan, found that 
correlation between grades of MEC and expression of Bcl-2 is 
statistically significant and can be used for the depicting the prog-
nosis of MEC along with other prognostic and clinicopathologi-
cal parameters.
Clinicopathologic features and prognosis of triple-
negative breast cancer in patients 40 years of age 
and younger in Saudi Arabia
In a retrospective review of 26 patients with TNBC, Abulkhair 
and colleagues from King AbdulAziz Medical City, Riyadh, Saudi 
Arabia, found there was no significant difference in 3-year sur-
vival between TNBC and non-TNBC patients, but the aggres-
siveness TNBC and survival was significantly worse in younger 
patients aged ≤40 years, compared to those over 40 years of age.
SyStEmatIC REVIEW
High-dose chemotherapy followed by stem 
cell transplantation in the management of 
retinoblastoma: a systematic review
Jaradat and colleagues from King Hussein Cancer Center, 
Amman, Jordan, found 15 studies with 101 patients that met in-
clusion criteria. Following treatment for metastatic and relapsed 
disease, 44 of 77 patients (57.1%) were alive with no evidence 
of disease at the time of follow-up, but there was a higher rate 
of local relapse in patients with CNS metastases (73.1%), who 
required thiotepa to improve tumor control.
     
CaSE REpORtS
Myeloid sarcoma of the vulva post-bone marrow 
transplant presenting as isolated extramedullary 
relapse in a patient with acute myeloid leukemia 
Ahmed and colleagues of King Faisal Specialist Hospital and 
Research Centre, Riyadh, Saudi Arabia describe a rare case of 
myeloid sarcoma as extramedullary relapse in a 41-year-old fe-
male. They emphasize that correct diagnosis is important because 
of its rarity and need for appropriate therapy. 
Post-dengue fever severe aplastic anemia: a rare 
association 
Ramzan and colleagues of the Institute of Child Health, Sir 
Ganga Ram Hospital, Delhi, India, describe a rare case of den-
gue-virus induced aplastic anemia in an 8-year-old girl that was 
successfully treated with antithymocytic immunoglobulin, meth-
ylprednisolone and cyclosporine.
